CompanyDrug

Keymed Biosciences’ CMG901 Shows Promising Results in Phase Ia Study for Solid Tumors

CompanyDeals

MDHC Group Raises Hundreds of Millions in Third Financing Round

CompanyDrug

Staidson’s STSP-0601 Begins Phase II Study for Hemophilia Treatment

CompanyDrug

Everest Medicines’ EVER206 Shows Positive Phase I Results in China

CompanyDeals

Bliss Bio Raises RMB 100 Million in Series B+ Financing for Oncology Pipeline

CompanyDrug

Junshi Biosciences’ Neotorch Study Achieves Superiority in Lung Cancer Trial

CompanyDrug

Hengrui’s EZH2 Inhibitor SHR2554 Nears Breakthrough Therapy Designation

CompanyDeals

Henlius Terminates TROP2 Antibody Licensing Deal with Chiome Bioscience

CompanyDeals

Structure Therapeutics Files for IPO on NASDAQ to Raise $119M

CompanyDrug

Hansoh’s HS-10517 Greenlit for COVID-19 Clinical Study by NMPA

CompanyDeals

Cowell Health Partners with Gilead Sciences to Enhance Drug Accessibility

CompanyDeals

IASO Bio Raises RMB 500 Million in Series C1 Funding for Cell Therapy Pipeline